A Safety Study of Hylan GF-20 to Treat Shoulder Osteoarthritis

Painful Shoulder Osteoarthritis Clinical Trial

Official title: Prospective, Single Arm, Pilot Study Evaluating the Safety and Efficacy of Hyaluronan (Hylan GF-20) in Patients With Painful Shoulder Osteoarthritis

Status Active, not recruiting

Clinical Trial Summary

The objective is to assess the safety and efficacy (over the course of 26 weeks) of 2 intra-articular (IA) Hylan GF-20 (Synvisc) injections in addition to customary care in patients with painful glenohumeral osteoarthritis.

Clinical Trial Description

n/a

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Osteoarthritis
• Painful Shoulder Osteoarthritis

• NCT number: NCT00253799
• Study type: Interventional
• Source: Northwestern Ophthalmic Institute S.C.
• Status: Active, not recruiting
• Phase: Phase 4
• Start date: December 2005